This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 Dec 7;355(23):2477-80.

doi: 10.1056/NEJMe068264. Epub 2006 Dec 4.

Thiazolidinediones for initial treatment of type 2 diabetes?

PMID: 17145743
DOI: 10.1056/NEJMe068264

Editorial

Thiazolidinediones for initial treatment of type 2 diabetes?

David M Nathan. N Engl J Med. 2006.

. 2006 Dec 7;355(23):2477-80.

doi: 10.1056/NEJMe068264. Epub 2006 Dec 4.

Author

PMID: 17145743
DOI: 10.1056/NEJMe068264

No abstract available

PubMed Disclaimer

Comment on

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'Neill MC, Zinman B, Viberti G; ADOPT Study Group. Kahn SE, et al. N Engl J Med. 2006 Dec 7;355(23):2427-43. doi: 10.1056/NEJMoa066224. Epub 2006 Dec 4. N Engl J Med. 2006. PMID: 17145742 Clinical Trial.

Similar articles

Choosing first-line therapy for management of type 2 diabetes.
Graber MA, Darby-Stewart A, Dachs R. Graber MA, et al. Am Fam Physician. 2008 Jan 1;77(1):16-7. Am Fam Physician. 2008. PMID: 18236820 No abstract available.
Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT).
Kahn SE, Haffner SM, Viberti G, Herman WH, Lachin JM, Kravitz BG, Yu D, Paul G, Holman RR, Zinman B; Diabetes Outcome Progression Trial (ADOPT) Study Group. Kahn SE, et al. Diabetes Care. 2010 Jan;33(1):177-83. doi: 10.2337/dc09-1661. Epub 2009 Oct 6. Diabetes Care. 2010. PMID: 19808911 Free PMC article. Clinical Trial.
Glycemic durability of monotherapy for diabetes.
Garg R. Garg R. N Engl J Med. 2007 Mar 29;356(13):1379; author reply 1380. N Engl J Med. 2007. PMID: 17402165 No abstract available.
Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R; American Heart Association; American Diabetes Association. Nesto RW, et al. Circulation. 2003 Dec 9;108(23):2941-8. doi: 10.1161/01.CIR.0000103683.99399.7E. Circulation. 2003. PMID: 14662691 Review. No abstract available.
What to add in with metformin in type 2 diabetes?
Petrie JR, Adler A, Vella S. Petrie JR, et al. QJM. 2011 Mar;104(3):185-92. doi: 10.1093/qjmed/hcq237. Epub 2010 Dec 13. QJM. 2011. PMID: 21156663 Review.

See all similar articles

Cited by

Durability of initial antidiabetic monotherapy and subsequent treatment adjustment patterns among newly treated type 2 diabetes patients.
Noh Y, Lee S, Shin S. Noh Y, et al. Ther Clin Risk Manag. 2018 Sep 3;14:1563-1571. doi: 10.2147/TCRM.S169964. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 30233191 Free PMC article.
Safety and Efficacy of D-Tagatose in Glycemic Control in Subjects with Type 2 Diabetes.
Ensor M, Banfield AB, Smith RR, Williams J, Lodder RA. Ensor M, et al. J Endocrinol Diabetes Obes. 2015;3(1):1065. Epub 2014 Dec 31. J Endocrinol Diabetes Obes. 2015. PMID: 27054147 Free PMC article.
Effects of Three Low-Doses of D-Tagatose on Glycemic Control Over Six Months in Subjects with Mild Type 2 Diabetes Mellitus Under Control with Diet and Exercise.
Ensor M, Williams J, Smith R, Banfield A, Lodder RA. Ensor M, et al. J Endocrinol Diabetes Obes. 2014 Oct;2(4):1057. J Endocrinol Diabetes Obes. 2014. PMID: 25580449 Free PMC article.
Design of glucagon-like Peptide-1 receptor agonist for diabetes mellitus from traditional chinese medicine.
Tang HC, Chen CY. Tang HC, et al. Evid Based Complement Alternat Med. 2014;2014:385120. doi: 10.1155/2014/385120. Epub 2014 May 6. Evid Based Complement Alternat Med. 2014. PMID: 24891870 Free PMC article.
Thiazolidinediones and bone.
Falchetti A, Masi L, Brandia ML. Falchetti A, et al. Clin Cases Miner Bone Metab. 2007 May;4(2):103-7. Clin Cases Miner Bone Metab. 2007. PMID: 22461209 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information